Growing prevalence of diseases is expected to drive the growth of India metronidazole market.
According to TechSci Research report, “India Metronidazole Market By Type of Process (Glyoxal Process, Ethidene Diamine Process, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Route of Administration (Oral v/s Intravenous), By Form (Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s Offline), By Product Type (Prescription v/s OTC), By Application (Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, Bacterial Vaginosis, Others), By Company, By Region, Forecast & Opportunities, FY2026”, the India metronidazole market is expected to grow at a steady rate during the forecast period on account of the extensive use of the drug in treatment of Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, among others. Additionally, the antibiotic is present in WHO’s list of essential drugs thereby increasing its demand and use. This in turn is expected to positively influence the market growth over the next few years. Furthermore, metronidazole serves as an alternative to vancomycin in the treatment of clostridium difficile colitis. However, side effects such as loss of appetite, headache, nausea, dizziness, blurred vision, drowsiness, fever among others are observed due to the intake of metronidazole thereby hampering the market growth through FY2026. Also, the drug is not safe for use in the early stages of pregnancy. Moreover, allergic reactions and sometimes seizures are also observed in certain cases due to consumption of metronidazole. Besides, the drug is not effective against viral infections such as common cold, flu, among others.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on“ India Metronidazole Market”
The India metronidazole market is segmented based on type of process, source, form, route of administration, distribution channel, product type, application, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. The in-house segment is expected to dominate the market on account of the presence of well-established big pharma giants and local players operating in the market. Additionally, the launch of schemes such as production linked incentive scheme for manufacturing of APIs locally in India will boost the status of domestic players thereby driving the segmental growth. Based on form, the market can be categorized into tablets, capsule, injection and others. The tablets segment is expected to dominate the market on account of the benefits such as easy availability, low cost, ability to split into two in case a low dose has to be administered, durability, long lasting effect, among others. Additionally, a single API can accommodate large dose of API as compared to a capsule. Based on distribution channel, the market can be split into online and offline. The offline segment is expected to dominate the market on account of the well established network of pharmacies in the country. The online segment is expected to register significant growth during forecast period due to the emergence of several online pharmacies and e-commerce platforms.
Unichem Laboratories Ltd., Aarey Drugs & Pharmaceuticals Ltd., Aarti Drugs Ltd., Lupin Limited, Abbott India Ltd., Atom Pharmaceuticals Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Aristo Pharmaceuticals Pvt. Ltd., Geno Pharmaceuticals Private Limited, Torrent Pharmaceuticals Ltd. and others are some of the leading players operating in India Metronidazole market. Companies operating in the market are using organic strategies such as product launches, mergers and acquisitions and research collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7196
Customers can also request for 10% free customization on this report.
“India metronidazole market is expected to witness growth during the forecast period on account of the growing focus of the government in making the country self-sufficient with respect to API manufacturing and drug development. With respect to this the government of India has launched few schemes and policies such as production linked incentive scheme, scheme for establishment of bulk drug parks, China plus one strategy, among others.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Metronidazole Market By Type of Process (Glyoxal Process, Ethidene Diamine Process, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Route of Administration (Oral v/s Intravenous), By Form (Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s Offline), By Product Type (Prescription v/s OTC), By Application (Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, Bacterial Vaginosis, Others), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India metronidazole market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India metronidazole market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017